Bal Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

338.54

303.10

280.37

249.31

170.67

Operating profit

32.44

26.03

23.20

26.32

6.26

Interest

15.24

12.16

10.40

11.96

12.42

Gross profit

20.56

16.03

19.29

17.06

-2.54

EPS (Rs)

6.50

3.90

5.78

6.14

-6.72

Other income

3.35

2.15

6.49

2.70

3.62

Stock adjustment

-1.06

-17.90

-4.85

5.13

-3.43

Raw material

181.57

176.45

162.95

135.47

79.44

Power and fuel

-

-

-

-

-

Employee expenses

56.11

51.91

44.46

39.62

48.77

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

69.48

66.61

54.61

42.77

39.64

Provisions made

-

-

-

-

-

Depreciation

8.45

7.48

7.24

7.26

7.03

Taxation

1.83

2.42

3.48

0.70

-0.04

Net profit / loss

10.27

6.12

8.57

9.10

-9.53

Extra ordinary item

-

-

-0.01

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

15.80

15.69

14.82

14.82

14.17

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

9.58

8.59

8.28

10.56

3.67

GPM (%)

6.01

5.25

6.73

6.77

-1.46

NPM (%)

3.00

2.01

2.99

3.61

-5.47